Cell Therapy for Cardiovascular Disease: A Comparison of Methods of Delivery
Authors:
Open Access
- 23 December 2010
- journal article
- review article
- Published by Springer Nature in Journal of Cardiovascular Translational Research
- Vol. 4 (2) , 177-181
Abstract
The field of myocardial regeneration utilizing novel cell-based therapies, gene transfer, and growth factors may prove to play an important role in the future management of ischemic heart disease and cardiomyopathy. Phases I and II clinical trials have been published for a variety of biologics utilizing four methods of delivery: systemic infusion, intracoronary infusion, transvenous coronary sinus, and intramyocardial. This review discusses the advantages and disadvantages of the delivery approaches above.Keywords
This publication has 33 references indexed in Scilit:
- Rationale and design of the Transendocardial Injection of Autologous Human Cells (bone marrow or mesenchymal) in Chronic Ischemic Left Ventricular Dysfunction and Heart Failure Secondary to Myocardial Infarction (TAC-HFT) trial: A randomized, double-blind, placebo-controlled study of safety and efficacyAmerican Heart Journal, 2011
- Delivering Stem Cells to the Heart in a Collagen Matrix Reduces Relocation of Cells to other Organs as Assessed by Nanoparticle TechnologyRegenerative Medicine, 2009
- Intracoronary delivery of mesenchymal stem cells at high flow rates after myocardial infarction improves distal coronary blood flow and decreases mortality in pigsCatheterization and Cardiovascular Interventions, 2008
- Direct Minimally Invasive Intramyocardial Injection of Bone Marrow-Derived AC133+ Stem Cells in Patients with Refractory Ischemia: Preliminary ResultsThe Thoracic and Cardiovascular Surgeon, 2008
- Transendocardial autologous bone marrow in chronic myocardial infarction using a helical needle catheter: 1-year follow-up in an open-label, nonrandomized, single-center pilot study (the TABMMI study)American Heart Journal, 2007
- Timing of intracoronary bone-marrow-derived stem cell transplantation after ST-elevation myocardial infarctionNature Clinical Practice Cardiovascular Medicine, 2006
- Safety and Feasibility of Autologous Myoblast Transplantation in Patients With Ischemic CardiomyopathyCirculation, 2005
- A randomized double blind placebo controlled multicenter pilot study of the safety and feasibility of AdGVVEGF121.10 via an intramyocardial injection catheter in patients with advanced coronary artery diseaseJACC, 2003
- Endoventricular Transplantation of Allogenic Skeletal Myoblasts in a Porcine Model of Myocardial InfarctionJournal of Endovascular Therapy, 2002
- Electromagnetic guidance for catheter-based transendocardial injection: a platform for intramyocardial angiogenesis therapyJACC, 2000